Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial

OBJECTIVE: Circulating levels of soluble receptor for advanced glycation end products (sRAGE) likely comprise both a secreted isoform (esRAGE) and wild-type RAGE cleaved from the cell membrane. Both sRAGE and esRAGE have been proposed as biomarkers of cardiovascular disease (CVD), but prospective da...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Colhoun, Helen M., Betteridge, D. John, Durrington, Paul, Hitman, Graham, Neil, Andrew, Livingstone, Shona, Charlton-Menys, Valentine, Bao, Weihang, DeMicco, David A., Preston, Gregory M., Deshmukh, Harshal, Tan, Kathryn, Fuller, John H.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2011
Matèries:
Complications
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3161327/
https://ncbi.nlm.nih.gov/pubmed/21771973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db11-0291
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars